At AstraZeneca, technology and science meet to change what is possible for patients. We are building a connected, end-to-end Enterprise AI engine — uniting data foundations, AI technology, process reinvention, and business-facing AI to accelerate results across the whole value chain. Success depends on being exceptional connectors: you will actively leverage existing capabilities, celebrate and promote reuse, export breakthrough ideas across geographies and functions, and obsess over scaling impact rather than building in isolation.
AI Science & Innovation (AISI) sits at the centre of AstraZeneca's R&D AI transformation. Our remit is to build, buy, and deliver the AI models and agents that change pipeline outcomes, across discovery, translational science, biomarkers, and clinical development.
Within AISI, the BioPharma Clinical Development AI team is building world-class AI capability to accelerate the design, conduct, and analysis of clinical trials across our BioPharmaceuticals pipeline — spanning both early and late phase programmes. We partner closely with clinical development, regulatory, and biometrics teams to bring better treatments to patients faster, while adhering to the highest evidentiary standards.
Bringing new treatments to patients demands scientific excellence at every stage of development. In the AI for Clinical Development, BioPharma AIR&D team, we focus on one of the most data-rich and decision-intensive parts of that journey: clinical development. Trial design, patient selection, dose optimisation, biomarker strategy, and safety evaluation each represent genuine opportunities where AI and machine learning can add rigour, speed, and precision — not as a replacement for clinical and statistical expertise, but as a powerful complement to it. We hold ourselves to measurable standards of improvement, and we build methods that can be evaluated, reproduced, and trusted in regulatory settings.
You will work across the enterprise to define and deliver on AstraZeneca's most pressing clinical development questions — collaborating in cross-functional teams spanning the key BioPharmaceuticals disease areas of cardiovascular, renal, metabolic disease, respiratory, and immunology. You and the team will apply new methods to measurably advance the late-stage drug pipeline, and you will help invent reusable approaches that scale across programmes and geographies.
AI for clinical development is a field in motion. Foundation models, agentic systems, and causal AI are advancing rapidly, and the regulatory and methodological frameworks around them are evolving in parallel. As an Associate Director, Data Scientist in the AI for Clinical Development team, you will be hands-on at the frontier — developing, evaluating, and deploying AI methods that directly inform clinical trial design and decision-making across early and late phase programmes. Every model you build will eventually touch a trial that decides whether a patient gets a better therapy. That is the bar we hold ourselves to.
Why AstraZeneca?
Here, technology and science meet to change what is possible for patients. You will join a company investing boldly in AI and data to become truly data-led, where unexpected teams come together to address problems that have never been solved before. We empower scientists to experiment, prototype early, fail forward, and partner credibly across communities — ML, clinical, biostatistics, regulatory.
We value learning agility and technical excellence equally. The strongest contributors here are those who learn fast, are comfortable with ambiguity, and obsess over real-world impact rather than building in isolation. Your work will directly influence trials that shape whether patients receive better therapies.
We balance the expectation of being in the office — on average at least three days per week — while respecting individual flexibility. Join us in our unique and ambitious world.
When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.
So, What's Next?
Are you ready to build AI that matters — at the intersection of machine learning, clinical science, and real patient impact? Submit your CV and cover letter and let us explore how your expertise can help AstraZeneca accelerate the next wave of breakthrough medicines.
Find out more at: https://careers.astrazeneca.com/...
#ClinicalAI #DataScience #AISI #MachineLearning #DataAI
21-sept-2026
05-oct-2026
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com.
Community Guidelines: bit.ly/2MgAcio